Pancreatic Cancer Non-resectable Clinical Trials

11 recruiting

Pancreatic Cancer Non-resectable Trials at a Glance

11 actively recruiting trials for pancreatic cancer non-resectable are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Hangzhou, Beijing, and Castellon. Lead sponsors running pancreatic cancer non-resectable studies include Zhejiang University, Englewood Hospital and Medical Center, and City of Hope Medical Center.

Browse pancreatic cancer non-resectable trials by phase

Treatments under study

About Pancreatic Cancer Non-resectable Clinical Trials

Looking for clinical trials for Pancreatic Cancer Non-resectable? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pancreatic Cancer Non-resectable trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pancreatic Cancer Non-resectable clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic NeoplasmsCancer of Pancreas+4 more
UNC Lineberger Comprehensive Cancer Center45 enrolled1 locationNCT03977233
Recruiting

Pancreatic Cancer Detection Consortium

Pancreatic CancerPancreatic CarcinomaPancreatic Ductal Adenocarcinoma+10 more
City of Hope Medical Center2,000 enrolled11 locationsNCT06388967
Recruiting
Not Applicable

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

Biliary Tract NeoplasmsPancreatic Cancer Non-resectableMalignant Biliary Obstruction
Hospital Universitari de Bellvitge128 enrolled10 locationsNCT06375967
Recruiting
Phase 2

Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

Colorectal Cancer MetastaticPancreatic Cancer MetastaticPancreatic Cancer Non-resectable
HealthPartners Institute64 enrolled1 locationNCT06605430
Recruiting
Phase 1Phase 2

Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer

Pancreatic CancerPancreatic CarcinomaPancreatic Cancer Stage IV+1 more
Essen Biotech60 enrolled1 locationNCT07066995
Recruiting

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-

Pancreatic Cancer Non-resectable
Englewood Hospital and Medical Center25 enrolled1 locationNCT06937996
Recruiting
Not Applicable

Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.

Pancreatic Cancer MetastaticPancreatic Cancer Non-resectable
Gansu Wuwei Tumor Hospital62 enrolled1 locationNCT06840067
Recruiting
Early Phase 1

Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer Non-resectable
Zhejiang University20 enrolled1 locationNCT06478459
Recruiting
Early Phase 1

A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer

Pancreatic Cancer Non-resectable
Zhejiang University30 enrolled1 locationNCT06503497
Recruiting
Not Applicable

Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

Pancreatic Cancer Non-resectable
Shanghai Proton and Heavy Ion Center48 enrolled1 locationNCT05424159
Recruiting
Not Applicable

Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer

Pain CancerPancreatic Cancer Non-resectableTumor Pancreas
Chinese University of Hong Kong94 enrolled1 locationNCT06160323